-
Google PR 0Trustworthiness Unknown
-
Avg. Daily Visitors N/AChild Safety Unknown
-
Avg. Daily Pageviews N/APrivacy Unknown
Biogen | Newsroom
Domain info
Location: | United States |
Registrant: | Biogen Idec MA Inc |
Hosted by: | Akamai Technologies, Inc. |
Registrar: | CSC Corporate Domains, Inc. |
Subnetworks: | 23.205.106.11, 23.205.106.26 |
Social Media Activities
- Facebook likes: -
- Twitter mentions: 2
- Google pluses: -
- LinkedIn mentions: -
- Pinterest pins: -
- StumbleUpon views: -
Web Safety
- This website is malware-free.
- Status ok
Sites associated with the same registrant
Whois
Media.biogen.com popular pages to visit
Biogen | News
The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.
Biogen Idec Presents Positive Interim Results from Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ:BIIB) announced data from a pre-specified interim analysis of PRIME, the Phase 1b study of aducanumab (BIIB037), in which aducanumab demons...
Biogen Presents New Data from Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) at Alzheimer’s
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today Biogen (NASDAQ: BIIB) announced new results from a prespecified interim analysis of PRIME, the Phase 1b placebo-controlled study of aducanumab (BIIB037) in pat...